6967-51-7

Basic information

• Product Name: 3,4-DIMETHOXYBENZYLAMINE HYDROCHLORIDE
• Synonyms: 3,4-DIMETHOXYBENZYLAMINE HYDROCHLORIDE;VERATRYLAMINE HYDROCHLORIDE
• CAS NO: 6967-51-7
• Molecular Formula: C₉H₁₃NO₂*ClH
• Molecular Weight: 203.67
• Product Categories: Anilines, Amides & Amines;Anisoles, Alkyloxy Compounds & Phenylacetates
• Mol File: 6967-51-7.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 291.1ºC at 760 mmHg
• Flash Point: 122.1ºC
• Appearance: /
• Density: 1.062 g/cm³
• CAS DataBase Reference: 3,4-DIMETHOXYBENZYLAMINE HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-DIMETHOXYBENZYLAMINE HYDROCHLORIDE(6967-51-7)
• EPA Substance Registry System: 3,4-DIMETHOXYBENZYLAMINE HYDROCHLORIDE(6967-51-7)

Safety Data

• Hazardous Substances Data: 6967-51-7(Hazardous Substances Data)

Usage

General Description

3,4-Dimethoxybenzylamine hydrochloride is a chemical compound belonging to the class of organic compounds known as benzylamines. It is comprised of a benzyl group, two methoxy groups attached at positions 3 and 4 of the aromatic ring, and an amine group which has been modified to form a hydrochloride salt. 3,4-Dimethoxybenzylamine hydrochloride is known for its reactivity and is commonly used in reactions as an intermediate or building block in chemical syntheses. Its physical characteristics include a white crystalline or powder form. The compound’s hydrochloride salt form enhances its solubility in water, enabling its use in various aqueous solutions. While it is utilized in various research and industrial applications, it is important to handle this compound with care due to its potential toxicity.

Upstream product

• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 2169-98-4 3,4-Dimethoxy-benzaldehyde oxime 
• 2024-83-1 veratronitrile 
• 5763-61-1 3,4-dimethoxybenzylamine 

Downstream Products

• 107186-25-4 4-chloro-5-(3,4-dimethoxybenzylamino)-2-(2-N,N-dimethylaminoethyl)-3(2H)pyridazinone 
• 23666-25-3 N⁶-(3,4-dimethoxybenzyl)adenosine 
• 128043-65-2 Ethyl 1-(3,4-dimethoxylbenzyl)-2,4,5-trioxoimidazolidine-3-acetate 
• 105686-10-0 1-(3,4-dimethoxybenzyl)imidazolidinetrione 
• 65609-19-0 1-(3,4-dimethoxybenzyl)urea 
• 123362-30-1 (4aS,5R,6S)-N-(3,4-dimethoxy)benzylbakankosin 

Relevant articles and documents

Fabrication of ω-Transaminase@Metal-Organic Framework Biocomposites for Efficiently Synthesizing Benzylamines and Pyridylmethylamines

In this study, ten ω-transaminases (ω-TAs) have been investigated to efficiently catalyze the synthesis of twenty-four functionalized benzylamines and pyridylmethylamines. We optimized the reactions, screened suitable amino donors and compared ω-transaminases activities for all aromatic aldehyde substrates. Under the optimized conditions, eighteen aromatic amines have been obtained with 60.4%–96.6% conversions and isolated only via simple extraction and recrystallization with 18.5%–81% yields on a preparative scale. Furthermore, we first immobilized the Bm-STA onto the MOFs via the physical adsorption to overcome the limitation of free enzyme and improve their industrial applications. The obtained Bm-STA/UiO-66-NH2 composites exhibited not only high enzymes loading (80.4 mg g?1) and enzyme activity recovery (95.8%), but also the better reusability, storage stability, pH stability and the tolerance to acetone and DMF.

APPLICATIONS OF N6-SUBSTITUTED ADENOSINE DERIVATIVE AND N6-SUBSTITUTED ADENINE DERIVATIVE TO CALMING, HYPNOSES, CONVULSION RESISTANCE, EPILEPTIC RESISTANCE, PARKINSON DISEASE RESISTANCE, AND DEMENTIA PREVENTION AND TREATMENT

PROBLEM TO BE SOLVED: To prepare analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. SOLUTION: The present invention relates to an N6-substituted adenosine derivative and an N6-substituted adenine derivative selected from the group consisting of specific compounds. The present invention also relates to a pharmaceutical composition at least comprising a therapeutically effective amount of the compounds and a pharmaceutically acceptable carrier. The invention further relates to the compounds used in preparation of analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. COPYRIGHT: (C)2016,JPO&INPIT

Sodium nitrite-catalyzed aerobic oxidative Csp2-Csp3 coupling: Direct construction of the 4-aryldihydroisoquinolinone moiety

A bioinspired approach for the construction of the 4- aryldihydroisoquinolinone moiety via direct oxidative Csp2-Csp 3 coupling has been developed, which uses inexpensive sodium nitrite as catalyst and environmentally benign oxygen in the air as terminal oxidant.